Your browser doesn't support javascript.
loading
Levomilnacipran ER 40 mg and 80 mg in patients with major depressive disorder: a phase III, randomized, double-blind, fixed-dose, placebo-controlled study.
Bakish, David; Bose, Anjana; Gommoll, Carl; Chen, Changzheng; Nunez, Rene; Greenberg, William M; Liebowitz, Michael; Khan, Arif.
Afiliação
  • Bakish D; Ottawa Psychopharmacology Clinic, Ottawa, Ont., Canada.
  • Bose A; Forest Research Institute, at time of study, Jersey City, NJ, USA.
  • Gommoll C; Forest Research Institute, Jersey City, NJ, USA.
  • Chen C; Forest Research Institute, Jersey City, NJ, USA.
  • Nunez R; Forest Research Institute, Jersey City, NJ, USA.
  • Greenberg WM; Forest Research Institute, Jersey City, NJ, USA.
  • Liebowitz M; Columbia University and The Medical Research Network, New York, NY, USA.
  • Khan A; Northwest Clinical Research Center, Bellevue, Wash., USA Department of Psychiatry and Behavioral Sciences, Duke University Medical School, Durham, NC, USA.
J Psychiatry Neurosci ; 39(1): 40-9, 2014 Jan.
Article em En | MEDLINE | ID: mdl-24144196
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ciclopropanos / Transtorno Depressivo Maior / Antidepressivos Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ciclopropanos / Transtorno Depressivo Maior / Antidepressivos Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2014 Tipo de documento: Article